SCHEMBL6166854

SCHEMBL6166854

C=C(Cc1ccnc(-c2cc(OC)c(OC(C)C)c(OC)c2)c1)N1CCC(=O)CC1

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 5/20 0.36
HCRTR2 O43614 5/20 0.36
PTGDR2 Q9Y5Y4 4/20 0.33
SYK P43405 4/20 0.33
PDE1A P54750 1/20 0.33
PDE1B Q01064 1/20 0.33
PDE1C Q14123 1/20 0.33
ABCB1 P08183 1/20 0.33
PREP P48147 1/20 0.32
JAK2 O60674 2/20 0.32
JAK1 P23458 2/20 0.32
TYK2 P29597 2/20 0.32
JAK3 P52333 2/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6169530 0.91 HCRTR1 (0.39) HCRTR1HCRTR2PDE1APDE1BPDE1C
SCHEMBL6167070 0.86 HCRTR1 (0.38) HCRTR1HCRTR2PTGDR2ABCB1PREP
Ethylene SCHEMBL4111191 0.84 HCRTR1 (0.41) HCRTR1HCRTR2JAK2JAK1TYK2
SCHEMBL4122785 0.84 HCRTR1 (0.42) HCRTR1HCRTR2JAK2JAK1TYK2
SCHEMBL4109886 0.77 FYN (0.41)
Ethylene SCHEMBL4115800 0.74 HCRTR1 (0.44) HCRTR1HCRTR2JAK2JAK1TYK2
SCHEMBL4109554 0.74 ALDH1A1 (0.37) HCRTR1HCRTR2
SCHEMBL4117342 0.74 HCRTR1 (0.45) HCRTR1HCRTR2JAK2JAK1TYK2
SCHEMBL27598696 0.72 PDE4D (0.43) HCRTR1HCRTR2
SCHEMBL13813557 0.70 ERN1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1494670-A1 MEDICINE FOR TREATING CANCER Kowa Co., Ltd. (JP) 2005-01-12 EP disclosed
WO-2003086397-A1 MEDICINE FOR TREATING CANCER KOWA CO., LTD. (JP) 2003-10-23 WO disclosed